Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    May 2017
  1. PRINTZ C
    CDC recommends only 2 HPV doses for younger adolescents.
    Cancer. 2017;123:1485.
    PubMed     Text format    


    February 2017
  2. BEADLE BM
    The impact of HPV testing for oropharyngeal cancers: Why the addendum matters.
    Cancer. 2017 Feb 27. doi: 10.1002/cncy.21842.
    PubMed     Text format    


    December 2016
  3. OVESTAD IT, Dalen I, Hansen E, Loge JL, et al
    Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Cancer. 2016 Dec 5. doi: 10.1002/cncy.21807.
    PubMed     Text format     Abstract available


    November 2016
  4. DE BROT L, Pellegrini B, Moretti ST, Carraro DM, et al
    Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.
    Cancer. 2016 Nov 21. doi: 10.1002/cncy.21789.
    PubMed     Text format     Abstract available


    October 2016
  5. PATADJI S, Li Z, Pradhan D, Zhao C, et al
    Significance of high-risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institution.
    Cancer. 2016 Oct 24. doi: 10.1002/cncy.21791.
    PubMed     Text format     Abstract available


  6. DOXTADER EE, Brainard JA, Underwood D, Chute DJ, et al
    Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Cancer. 2016 Oct 12. doi: 10.1002/cncy.21783.
    PubMed     Text format     Abstract available


    June 2016
  7. GARDEN AS, Fuller CD, Rosenthal DI, William WN Jr, et al
    Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer.
    Cancer. 2016;122:1702-7.
    PubMed     Text format     Abstract available


    May 2016
  8. BISHOP JA, Ha PK
    Human papillomavirus detection in a "Digital" age.
    Cancer. 2016;122:1502-4.
    PubMed     Text format    


  9. BIRON VL, Kostiuk M, Isaac A, Puttagunta L, et al
    Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
    Cancer. 2016;122:1544-51.
    PubMed     Text format     Abstract available


  10. CRACCHIOLO JR, Baxi SS, Morris LG, Ganly I, et al
    Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.
    Cancer. 2016;122:1523-32.
    PubMed     Text format     Abstract available


  11. PATEL MA, Blackford AL, Rettig EM, Richmon JD, et al
    Rising population of survivors of oral squamous cell cancer in the United States.
    Cancer. 2016;122:1380-7.
    PubMed     Text format     Abstract available


  12. REUSCHENBACH M, Pauligk C, Karbach J, Rafiyan MR, et al
    A phase 1/2a study to test the safety and immunogenicity of a p16(INK4a) peptide vaccine in patients with advanced human papillomavirus-associated cancers.
    Cancer. 2016;122:1425-33.
    PubMed     Text format     Abstract available


    March 2016
  13. WRIGHT BJ, Conlin AK, Allen HL, Tsui J, et al
    What does Medicaid expansion mean for cancer screening and prevention? Results from a randomized trial on the impacts of acquiring Medicaid coverage.
    Cancer. 2016;122:791-7.
    PubMed     Text format     Abstract available


    February 2016
  14. MCDOWELL LJ, Young RJ, Johnston ML, Tan TJ, et al
    p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    Cancer. 2016 Feb 16. doi: 10.1002/cncr.29901.
    PubMed     Text format     Abstract available


  15. FRAKES JM, Naghavi AO, Demetriou SK, Strom TJ, et al
    Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Cancer. 2016;122:634-41.
    PubMed     Text format     Abstract available


    January 2016

  16. Numbers game: Researchers explore whether fewer than 3 doses of HPV vaccine are effective.
    Cancer. 2016;122:11-2.
    PubMed     Text format    


    December 2015
  17. BYCHKOVSKY BL, Ferreyra ME, Strasser-Weippl K, Herold CI, et al
    Cervical cancer control in Latin America: A call to action.
    Cancer. 2015 Dec 15. doi: 10.1002/cncr.29813.
    PubMed     Text format     Abstract available


    October 2015
  18. SCHENKER Y, Arnold RM, Bauman JE, Heron DE, et al
    An enhanced role for palliative care in the multidisciplinary approach to high-risk head and neck cancer.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29754.
    PubMed     Text format    


  19. QIAN G, Jiang N, Wang D, Newman S, et al
    Heregulin and HER3 are prognostic biomarkers in oropharyngeal squamous cell carcinoma.
    Cancer. 2015;121:3600-11.
    PubMed     Text format     Abstract available


  20. TEMKIN SM, Seibel NL
    Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers.
    Cancer. 2015;121:3395-402.
    PubMed     Text format     Abstract available


  21. DAHLSTROM KR, Li G, Hussey CS, Vo JT, et al
    Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Cancer. 2015;121:3455-64.
    PubMed     Text format     Abstract available


    September 2015
  22. PRINTZ C
    HPV vaccine protects at multiple sites, even for some previously exposed.
    Cancer. 2015;121:2863.
    PubMed     Text format    


    August 2015
  23. BRAR H, Covens A
    Trends in cervical intraepithelial neoplasia Grade 2+ after human papillomavirus vaccination: The devil is in the details.
    Cancer. 2015;121:2674-7.
    PubMed     Text format    


  24. PRINTZ C
    ACS report: Progress lags in some cancer control efforts.
    Cancer. 2015;121:2478-9.
    PubMed     Text format    


  25. HAJDU SI, Vadmal M, Tang P
    A note from history: Landmarks in history of cancer, part 7.
    Cancer. 2015;121:2480-513.
    PubMed     Text format     Abstract available


  26. KEANE FK, Chen YH, Neville BA, Tishler RB, et al
    Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.
    Cancer. 2015;121:2594-602.
    PubMed     Text format     Abstract available


    July 2015
  27. PRINTZ C
    Physicians say HPV testing alone can screen for cervical cancer.
    Cancer. 2015;121:2105.
    PubMed     Text format    


    June 2015
  28. HARIRI S, Johnson ML, Bennett NM, Bauer HM, et al
    Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.
    Cancer. 2015 Jun 22. doi: 10.1002/cncr.29266.
    PubMed     Text format     Abstract available


  29. GRAHAM DM, Isaranuwatchai W, Habbous S, de Oliveira C, et al
    A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer.
    Cancer. 2015;121:1785-92.
    PubMed     Text format     Abstract available


  30. SINHA P, Piccirillo JF, Kallogjeri D, Spitznagel EL, et al
    The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines.
    Cancer. 2015;121:1747-54.
    PubMed     Text format     Abstract available


    May 2015
  31. WEINMANN S, Williams AE, Kamineni A, Buist DS, et al
    Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007.
    Cancer. 2015 May 18. doi: 10.1002/cncr.29445.
    PubMed     Text format     Abstract available


  32. PRINTZ C
    HPV vaccination rates remain low: Cancer prevention community needs to continue promoting the vaccine's safety and efficacy, say experts.
    Cancer. 2015;121:1341-3.
    PubMed     Text format    


    April 2015
  33. PRINTZ C
    FDA approves Gardasil 9 for more types of HPV.
    Cancer. 2015;121:1156-7.
    PubMed     Text format    


    March 2015
  34. GUO T, Qualliotine JR, Ha PK, Califano JA, et al
    Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Cancer. 2015 Mar 17. doi: 10.1002/cncr.29323.
    PubMed     Text format     Abstract available


  35. REUSCHENBACH M, Huebbers CU, Prigge ES, Bermejo JL, et al
    Methylation status of HPV16 E2-binding sites classifies subtypes of HPV-associated oropharyngeal cancers.
    Cancer. 2015 Mar 2. doi: 10.1002/cncr.29315.
    PubMed     Text format     Abstract available


    January 2015
  36. IYER NG, Tan DS, Tan V, Wang W, et al
    Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Cancer. 2015 Jan 29. doi: 10.1002/cncr.29251.
    PubMed     Text format     Abstract available


  37. PRINTZ C
    Urine HPV Test Could Offer a Noninvasive Alternative.
    Cancer. 2015;121:165.
    PubMed     Text format    


    December 2014
  38. PRINTZ C
    Study points to value of HPV screening for cervical cancer: Test may be viable alternative to Pap test.
    Cancer. 2014;120:3589-3590.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: